1. Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China
2. Department of Hematology, Pukou CLL Center, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China
3. Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China
4. The Fourth Hospital of Hebei Medical University, Shijiazhuang, China
5. Neurosurgery Center, Beijing Tiantan Hospital, Capital Medical University, Beijing,, China
6. Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
7. Department of Hematology, West China Hospital of Sichuan University, Chengdu, China
8. National Clinical Research Center for Blood Diseases, State Key Laboratory of Experimental Hematology, Blood Diseases Hospital & Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
9. Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
10. Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
11. Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
12. Department of Hematology, The First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, China
13. Beijing InnoCare Pharma Tech Co., Ltd, Beijing, China